tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Bryan Brokmeier, 28 are a BUY (93.33%), 2 are a HOLD (6.67%).
Analyst Bryan Brokmeier works with a stock forecast success ratio of 76.04% fulfilled within 535.88 days on average. Previously, Bryan Brokmeier worked at CANTOR FITZGERALD.
Bryan Brokmeier’s has documented 62 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on TTOO, T2 Biosystms at 03-May-2017.
Analyst best performing recommendations are on PACB (PACIFIC BIOSCIENCES OF CALIFORNIA).
The best stock recommendation documented was for TTOO (T2 BIOSYSTMS) at 5/3/2017. The price target of $30000 was fulfilled within 133 days with a profit of $10150 (51.13%) receiving and performance score of 3.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
16
7 days ago
1/2 (50%)
$4.48 (38.89%)
102
Hold
2.5
$1.14 (83.82%)
7
10 days ago
0/4 (0%)
$0.95 (61.29%)
Buy
8
$6.64 (488.24%)
15
11 days ago
2/4 (50%)
$6.54 (447.95%)
26
Buy
12
$10.64 (782.35%)
12.5
2 months 13 days ago
1/4 (25%)
$6.26 (109.06%)
109
Hold
4 months 16 days ago
3/3 (100%)
$-4.36 (-12.69%)
129
What Year was the first public recommendation made by Bryan Brokmeier?
